NHSA to Hold Collective Meetings with Designated Psychiatric Healthcare Institutions

February 4, 2026 – The National Healthcare Security Administration (NHSA) issued a notice aimed at further strengthening the management of designated psychiatric healthcare institutions (including psychiatric departments of general hospitals, collectively referred to as designated psychiatric institutions) and rigorously rectifying irregularities involving illegal use of healthcare funds. The notice requires provincial healthcare security departments to organize collective meetings with the heads of all designated psychiatric institutions within their jurisdictions by this Sunday to provide detailed explanations of relevant healthcare security laws, regulations, and supervisory policies.

At the same time, provincial healthcare security departments should use recent issues exposed by the media at designated psychiatric institutions in Xiangyang and Yichang, Hubei Province, as well as various problems identified in previous unannounced inspections, as cautionary case studies to educate relevant institutions. This is intended to enhance awareness among designated psychiatric institutions regarding the lawful and compliant use of healthcare funds.

Additionally, provincial healthcare security departments must organize all designated psychiatric institutions within their jurisdictions to conduct comprehensive self-inspections and self-corrections starting immediately. The focus of these efforts should be on illegal activities such as inducing hospitalizations, fabricating hospital stays, falsifying medical conditions or treatments, forging documents, and charging improper fees—though not limited to these areas. The aim is to reinforce institutional accountability and the management responsibilities of their heads. All designated psychiatric institutions must complete self-inspections and corrections by March 15, submit written reports, and return any funds involved in illegal activities. Provincial healthcare security departments are required to report the self-inspection outcomes within their jurisdictions to the NHSA by the end of March.

Furthermore, the NHSA will prioritize designated psychiatric institutions for special unannounced inspections this year. Institutions found to have illegally used healthcare funds or that fail to conduct adequate self-inspections will face severe penalties in accordance with laws and regulations, with serious cases referred to public security authorities.

Within designated psychiatric institutions, the management of potent narcotic drugs like fentanyl-class medications is critically important. Their secure storage and precise use directly impact patient safety and institutional compliance. The Firebird Fentanyl-Class Drugs Dedicated Smart Cabinet has been meticulously developed to meet these specialized needs.

Precise Identification and Access Control

The Firebird Fentanyl-Class Drugs Dedicated Smart Cabinet employs advanced biometric technologies such as fingerprint and facial recognition, combined with smart card systems, to achieve precise identity verification of personnel accessing medications. Only authorized personnel who pass strict authentication can open the cabinet doors and retrieve drugs, effectively preventing unauthorized access and ensuring drug safety at the source. The system also records detailed operational information for each user, including retrieval time, drug name, quantity, etc., providing reliable data for drug usage tracing.

The cabinet is equipped with high-precision sensors that continuously monitor internal environmental parameters such as temperature, humidity, and light exposure, ensuring fentanyl-class drugs are stored under optimal conditions. If any parameter deviates from the set range, the system immediately triggers an alert, prompting management staff to take corrective action to preserve drug quality. Additionally, the cabinet features an abnormal activity alarm; if the door is illegally opened or forcibly tampered with, an alert is instantly activated to facilitate timely intervention and prevent theft or misuse.

Through seamless integration with hospital information systems, the Firebird Smart Cabinet enables real-time inventory updates and precise management. After each medication retrieval, the system automatically deducts the corresponding quantity from inventory and issues replenishment alerts when stock falls below predefined thresholds. It also supports automated auditing functions: management staff can initiate audit tasks via the system, prompting the cabinet to scan and tally internal drugs, generating detailed audit reports. This significantly enhances auditing efficiency and reduces human error.

Regarding data security, the Firebird Smart Cabinet utilizes multi-layer encryption technology to protect all data generated during drug storage and retrieval, ensuring confidentiality and integrity. The system strictly adheres to national laws, regulations, and healthcare industry standards for data storage and backup, providing strong support for institutional compliance operations.

With its precise access control, intelligent monitoring and alert capabilities, efficient inventory management, and reliable data security, the Firebird Fentanyl-Class Drugs Dedicated Smart Cabinet offers a comprehensive management solution for designated psychiatric institutions. It effectively elevates the management standards for special medications, safeguarding patient medication safety and ensuring institutional compliance.